NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 230 filers reported holding NEKTAR THERAPEUTICS in Q3 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $8,393 | -68.9% | 11,940 | 0.0% | 0.00% | – |
| Q4 2022 | $26,985 | -29.0% | 11,940 | 0.0% | 0.00% | – |
| Q3 2022 | $38,000 | -19.1% | 11,940 | -4.1% | 0.00% | – |
| Q2 2022 | $47,000 | -94.3% | 12,452 | -46.1% | 0.00% | -100.0% |
| Q2 2019 | $822,000 | -40.9% | 23,089 | -44.2% | 0.00% | -33.3% |
| Q1 2019 | $1,391,000 | +273.9% | 41,397 | +265.7% | 0.00% | +200.0% |
| Q4 2018 | $372,000 | -60.3% | 11,319 | -26.3% | 0.00% | -50.0% |
| Q3 2018 | $936,000 | +218.4% | 15,354 | +155.2% | 0.00% | +100.0% |
| Q2 2018 | $294,000 | -32.6% | 6,017 | +46.8% | 0.00% | 0.0% |
| Q1 2018 | $436,000 | -6.0% | 4,099 | -89.8% | 0.00% | -50.0% |
| Q2 2013 | $464,000 | – | 40,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |